Kevzara subcutaneous injection 150mg autoinjector, manufactured by Sanofi, contains Sarilumab (genetical recombination) (YJ code: 3999444G3025, 150mg 1.14mL 1 kit). This IL-6 receptor antagonist treats moderately to severely active rheumatoid arthritis in adults who have not responded sufficiently to other DMARDs.
Kevzara subcutaneous injection 150mg autoinjector
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).